ribavirin has been researched along with Hepatic Veno Occlusive Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersson, J; Aschan, J; Björkstrand, B; Hägglund, H; Ljungman, P; Lönnqvist, B; Ringdén, O; Winiarski, J | 1 |
1 other study(ies) available for ribavirin and Hepatic Veno Occlusive Disease
Article | Year |
---|---|
Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantation.
Topics: Administration, Oral; Adult; Alanine Transaminase; Antiviral Agents; Bone Marrow Transplantation; Child; Hepacivirus; Hepatic Veno-Occlusive Disease; Hepatitis C; Humans; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Safety; Time Factors; Transplantation, Homologous | 1996 |